Alzheimers Resources

Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation:

Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic:

Activation of the CB2 receptor system reverses amyloid-induced memory deficiency:

Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease: